New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System ...
Add Yahoo as a preferred source to see more of our stories on Google. Your device's unique device identifier and model number are on the back of your receiver. Some of Dexcom's continuous glucose ...
Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...
Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointmentDUBLIN, ...
Zydus Lifesciences launches AI-powered CGM devices Diasens and GlucoLive for diabetes and CKD management, enabling continuous glucose tracking via the GoodFlip app.
Best Buy plans to start selling continuous glucose monitors in the next few weeks, in the tech retailer’s first foray into prescription-based medical device sales. The company plans to sell the Dexcom ...
The Food and Drug Administration on Tuesday approved expanded use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System. The system was originally approved to complement — not replace — ...
Dexcom G7 is available for people with all types of diabetes ages two years and older, giving more Canadians than ever access to a simple, accurate 1 and effective diabetes management solution BURNABY ...
Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...
A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results